Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05221567 |
Other study ID # |
ModumBad chronic depression |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 1, 2012 |
Est. completion date |
December 31, 2017 |
Study information
Verified date |
February 2022 |
Source |
Modum Bad |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The study evaluates whether Intensive psychotherapy show superior effect on chronic
depression over TAU
Description:
Background: Accumulating evidence indicates that intensive psychotherapy (i.e., greater
number of treatment sessions per time unit) improves outcomes for patients with mental health
problems. However, few studies have investigated whether patients with chronic depression
(CD) benefit from treatment with higher intensity. The main purpose of this study is to
investigate if intensive psychotherapy could improve treatment for patients with chronic
depression (CD). The primary research question is whether two intensive psychodynamic
inpatient treatments, affect phobia therapy (APT) and VITA, are superior to low intensity
treatment (TAU) at completion of treatment. To indicate if a potential difference between
intensive treatment and TAU is due to the intensity of the therapy, the study contrasts two
therapies with similar intensity, but different theoretical rationales. Methods: 280 patients
with CD are included in a naturalistic study. Patients are assessed at four time points;
assessment, start of therapy, end of therapy and 1-year follow-up. Three comparisons are
performed with patients matched across groups; Intensive treatment (APT + VITA) vs TAU during
treatment, APT vs VITA during treatment and APT vs VITA during follow-up. The outcome measure
is the BDI-II.